The mission of Mannat Fertility is to assist couples in conceiving and to increase the chances of those couples having a healthy child. One of the newer technologies to help achieve such an objective is Pre-implantation Genetic Screening (PGS). This is a world-renowned technique employed during IVF in which embryos are screened in terms of chromosomal deviation prior to their implantation into the womb.

PGS can improve the chances of a successful implantation, reduce miscarried delivery, and the delivery of a healthy child by screening in advance the embryos.

What is Pre-implantation Genetic Screening (PGS)?

Preimplantation genetic screening is an embryo-based test carried out in a lab on embryos produced by IVF. It entails deliberately examining a couple of cells in every embryo to find out whether the right number of chromosomes is present.

A normal embryo of healthy organisms contains 46 chromosomes (23 pairs). An insufficient or excess number of chromosomes (aneuploidy) may cause implantation failure, miscarriage or birth defects. GS enables fertility specialists to pre-select the chromosomally normal embryos to be transferred to a woman, giving couples the best opportunity of a successful pregnancy.